Skip to main content
logo
Bright Minds Biosciences Inc. (DRUG)
NASDAQ: DRUG · Real-Time Price · USD
49.65
-1.04 (-2.06%)
Oct 5, 2026, 10:42 AM EDT - Market open

Bright Minds Biosciences Ratios and Metrics

Millions USD. Fiscal year is Oct - Sep.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Market Capitalization
488429562085
Market Cap Growth
18.76%8742.00%-18.98%-70.74%-75.79%-
Enterprise Value
273393001467
Last Close Price
50.6960.661.171.606.1535.71

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
PB Ratio
2.257.291.191.232.675.51
P/TBV Ratio
2.257.291.191.232.675.52

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Debt / Equity Ratio
00.000.020.010.01-
Net Debt / Equity Ratio
-1.00-1.01-1.01-1.01-1.09-1.02
Quick Ratio
121.4435.6810.9224.168.0031.12
Current Ratio
121.9736.1011.3224.268.1131.38
Return on Equity (ROE)
-13.63%-27.93%-46.18%-86.02%-99.95%-85.94%
Return on Assets (ROA)
-13.50%-18.80%-25.28%-47.45%-57.32%-51.52%
Return on Capital Employed (ROCE)
-12.70%-16.60%-47.10%-109.10%-138.80%-44.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Earnings Yield
-3.53%-2.04%-42.70%-90.90%-53.20%-8.09%
Buyback Yield / Dilution
-38.94%-59.58%-15.87%-50.58%-37.64%-148.42%
SEC Filings: 10-K · 10-Q